Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- befree-2016 importedOn "2016-02-19" NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_assertion wasGeneratedBy ECO_0000203 NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_assertion wasDerivedFrom befree-2016 NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_assertion SIO_000772 15548710 NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_assertion evidence source_evidence_literature NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.
- NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_assertion description "[Additionally, inhibition of PI3K with a small molecular weight inhibitor (LY294002) was able to potentiate the antineoplastic activity of both doxorubicin and paclitaxel in CaP cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469426.RA3L-BfHud4au_5tE_y8FdT314HYOYEhUH-gAU7SCAh3Q130_provenance.